Thromboembolism

Cancer-Associated Thrombosis: An Overview

Cancer-Associated Thrombosis: An Overview

This review examines the epidemiology and pathophysiology of cancer-associated thrombosis, risk factors, and new predictive biomarkers for venous thromboembolism (VTE).

Semuloparin Prophylaxis Effective in Cancer Patients

Semuloparin Prophylaxis Effective in Cancer Patients

Semuloparin prophylaxis reduces the incidence of thromboembolic events during chemotherapy, with no increase in major bleeding.

Oncology Nurse Advisor Forum - March/April 2011

The Advisor Forum panel answers nurses' questions about patient care, treatment regimens, and oncology nursing.

Risk of venous thromboembolism

Treating patients with the recombinant monoclonal antibody bevacizumab carries a significant risk of venous thromboembolism (VTE), a meta-analysis has shown.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs